Fall 2024 edition provides insights into groundbreaking specialty solutions for managed care

Cover image for The state of value-based contracting 2.0 An update on Medicaid payment models and opportunities Prime Therapeutics Value-based contracts (VBCs) are performance-based reimbursement...

Abby Kim, PharmD, BCOP, shares how artificial intelligence and novel screening tools are helping to prevent and detect cancer better and sooner

cover image for Drug Approvals: December 2024 Critical updates in an ever-changing environment Prime Therapeutics /drug-approvals-december-2024 About Prime Therapeutics Prime Therapeutics logo...

Cover image for Drug approvals Critical updates in an ever-changing environment  Prime Therapeutics /drug-approvals-december-2024 About Prime Therapeutics Prime Therapeutics logo Prime Therapeutics...

Cover image for Summer 2023 Prime Therapeutics Report Gene Therapy Update Prime Therapeutics https://issuu.com/primetherapeutics/docs/2023_pt_summer_report_pdf?fr=xKAE9_zU1NQ Explore the report ...

Prime Therapeutics will add Humira biosimilars in the same position in its formulary as the original drug, joining other pharmaceutical benefit managers in announcing similar policies

Oncology Insights: First-in-class bladder cancer therapy and the Bacillus Calmette-Guérin (BCG) shortage

cover image for Drug Approvals: November 2024 Critical updates in an ever-changing environment Prime Therapeutics /drug-approvals-november-2024 Prime Therapeutics’ Drug Approvals provides an...

cover image Drug Approvals: April 2025 Monthly update on newly approved specialty and traditional drugs, new indications and first-time generic launches Prime Therapeutics...

Cover image for Drug Approvals: March 2025 Monthly update on newly approved specialty and traditional drugs, new indications and first-time generic launches Prime Therapeutics...

Cover image for Drug Approvals: February 2025 Monthly update on newly approved specialty and traditional drugs, new indications and first-time generic launches Prime Therapeutics...

Cover image for Drug Approvals: July 2024 Monthly update on newly approved specialty and traditional drugs, new indications and first-time generic launches Prime Therapeutics...

cover image This monthly update of United States (U.S.) Food and Drug Administration (FDA) approvals provides a review of newly approved specialty drugs, new indications and recent first-time...

Cover image for Summer 2024 Prime Therapeutics Report Pulmonary arterial hypertension: Exciting new approval and payer impact Prime Therapeutics /2024-summer-prime-therapeutics-report The Prime...

Cover image This high-level drug overview analyzes medical pharmacy claims across commercial, Medicare and Medicaid populations. Prime Therapeutics /2026-medical-pharmacy-trend-report-part-2 The...

Jessica Johnson, clinical consultant at Prime's Special Investigations Unit, shares tips to stay safe when using online pharmacies

New continuing education course showcases her expertise in biomarker testing and targeted therapy for EGFR-mutated NSCLC

Corporate Equality Index is a prominent benchmarking survey and report measuring corporate policies and practices related to LGBTQ+ workplace equality

Prime is honored to announce its information technology (IT) department’s Quality Excellence Center (QEC), together with Infosys, received the North American Software Testing Award (NASTA) for Best...